Johns Hopkins spinout Neuraly launches with $36M funding round - Technical.ly Baltimore

Business

Jul. 20, 2018 12:59 pm

Johns Hopkins spinout Neuraly launches with $36M funding round

The Maryland biotech startup is developing new treatments for Parkinson's disease and Alzheimer’s disease.
Lab space at Johns Hopkins’ FastForward 1812.

Lab space at Johns Hopkins' FastForward 1812.

(Photo by Stephen Babcock)

A Johns Hopkins biotech spinout working on new treatments for Alzheimer’s disease and Parkison’s disease officially launched with lots of fuel in the tank.

Neuraly said it raised $36 million in Series A funding from Korean venture funds including Smilegate Investment, InterVest, LB Investment, Magna Investment, Geon Investment and Dongkoo Bio&PharmaOctave Life Sciences and Maryland Venture Fund also participated.

The technology behind the treatment was born at the Johns Hopkins School of Medicine, and grew out of work by neuroscientists led by Institute for Cell Engineering director Ted Dawson. The company formed in 2016 as leaders looked to bring changes to treatment of neurodegenerative disorders.

“Currently, there aren’t any treatments that reverse, stop, or even slow neurodegeneration in diseases like Parkinson’s and Alzheimer’s. The treatments that do exist – all symptomatic – provide only temporary improvement in motor and cognitive function, but even these become less effective over time,” CEO Seulki Lee said in a statemen

Lee said the company is seeing promising early results in the potential for its main underlying product, called NLY01, to slow the progression of the diseases.

The Germantown-based company is looking to move into clinical trials in late 2018.

It’s the second eye-catching funding round from a Hopkins-originated biotech company this summer. WindMIL Therapeutics, which is targeting cancerposted a $32.5 million Series B round in June.

-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

Meet the Aerium: An algae air purifier created by IMET PhD candidates

AgeneBio receives $3.4M for development of Alzheimer’s treatment

Laureate founder Douglas Becker is now leading Cintana Education

SPONSORED

Baltimore

Why two eminent Baltimore higher-ed institutions collaborated to create this unique dual degree program

Baltimore, MD

14 West

Scrum Master

Apply Now

Baltimore, MD

14 West

Lead Qlik Developer

Apply Now

Baltimore, MD

14 West

Senior Qlik Developer

Apply Now

Frederick’s Veralox Therapeutics raises $5.4M seed round

These 9 companies are entering Conscious Venture Lab’s accelerator

Why two eminent Baltimore higher-ed institutions collaborated to create this unique dual degree program

SPONSORED

Baltimore

What Asymmetrik is doing to help lead healthcare’s digital transformation

Baltimore, MD

14 West

Qlik Developer

Apply Now

Baltimore

14 West

Senior Business Analyst

Apply Now

Offsite

Philadelphia Home

Social Media Catalyst

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!